EngagePoint

2017年8月21日

EngagePoint命名2013 Inc . 500 | 5000年增長最快的民營企業列表Veristat今天宣布被公司承認連續第三年。雜誌是美國發展最快的民營企業之一。Veristat於2015年加入列表。“Veristat榮幸被命名為5000年著名的公司連續第三年,”帕特裏克•弗拉納根說首席執行官Veristat”,我們的增長是受客戶需求和熱情幫助客戶加速提高生活質量和拯救生命的治療在臨床開發和監管部門的批準過程。我很自豪地成為Veristat團隊的一部分。每個人在Veristat致力於指導我們的客戶項目的成功和展品的堅定承諾改善人民的生活每一天。“Veristat是一個提供全麵服務的臨床研究機構(CRO),幫助製藥和生物技術公司設計、行為,分析並提交結果的研究得到監管部門的批準。過去一年,Veristat添加超過60才華橫溢的團隊成員,協助我們的客戶通過臨床發展規劃、設計和規劃的執行臨床試驗和導航的監管提交過程。此外,我們發起了一項戰略谘詢業務部門提供監管、臨床、醫學和統計谘詢支持我們的客戶在整個規劃和持續時間的臨床發展項目。我們還擴大了我們的操作進入歐洲,打開第五辦公室在2016年位於北卡羅萊納。帕特裏克·弗拉納根說:“我們很自豪能成為生物技術產業的戰略貢獻者。 The collaborations we participated in over the past year has led to 9 recent drug approvals on behalf of our clients. Our contribution to these life enhancing programs is a point of pride for every Veristat team member.” Earlier this year, Veristat was recognized by the Boston Business Journal on its “Fast 50” list of the 50 fastest growing private firms in Massachusetts. Today’s Inc. 5000 ranking is yet another accolade of Veristat that measures and endorses the growth of companies across the United States. Since 1982, Inc. Magazine has ranked the fastest-growing private companies in the United States and published the results on its annual Inc. 5000 list. The 2017 Inc. 5000 is ranked according to percentage revenue growth when comparing 2013 to 2016. To learn more and to view the 2017 Inc. 5000 list visit: https://www.inc.com/inc5000/list/2017 . About Veristat: Veristat is a consultative clinical research organization (CRO) that is committed to partnering with pharmaceutical, biotechnology and medical device firms to advance their therapies through the clinical development and regulatory submission process. Veristat helps clients solve the unique and complex challenges that arise when trying to accelerate therapies along the development pathway. Veristat provides experience-based strategic decision-making, the operational efficiencies to manage and monitor international trials, the biometrics expertise to collect, analyze & report clinical trial data to various regulatory agencies, and the therapeutic and medical proficiency to mastermind the entire process. Ultimately, we guide our clients to market success so that their therapies become available to improve and save people’s lives. For more information, visit www.veristat.com . View source version on businesswire.com: http://www.businesswire.com/news/home/20170821005078/en/ Veristat Contact: